U.S. justices block generic drug design defect lawsuits

WASHINGTON, June 24 Mon Jun 24, 2013 10:15am EDT

WASHINGTON, June 24 (Reuters) - The U.S. Supreme Court ruled on Monday that makers of generic drugs already approved by the U.S. Food and Drug Administration cannot be held liable under state law for claims of design defects.

In a 5-4 vote, the court ruled for Mutual Pharmaceutical Co, a unit of URL Pharma, owned by Sun Pharmaceutical Industries .

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.